Your browser doesn't support javascript.
loading
Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer.
Koch, Maximilian; de Jong, Johannes S; Glatz, Jürgen; Symvoulidis, Panagiotis; Lamberts, Laetitia E; Adams, Arthur L L; Kranendonk, Mariëtte E G; Terwisscha van Scheltinga, Anton G T; Aichler, Michaela; Jansen, Liesbeth; de Vries, Jakob; Lub-de Hooge, Marjolijn N; Schröder, Carolien P; Jorritsma-Smit, Annelies; Linssen, Matthijs D; de Boer, Esther; van der Vegt, Bert; Nagengast, Wouter B; Elias, Sjoerd G; Oliveira, Sabrina; Witkamp, Arjen J; Mali, Willem P T M; Van der Wall, Elsken; Garcia-Allende, P Beatriz; van Diest, Paul J; de Vries, Elisabeth G E; Walch, Axel; van Dam, Gooitzen M; Ntziachristos, Vasilis.
Afiliação
  • Koch M; Chair for Biological Imaging, Technical University of Munich, München, Germany.
  • de Jong JS; Institute for Biological and Medical Imaging, Helmholtz Zentrum München, München, Germany.
  • Glatz J; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Symvoulidis P; Chair for Biological Imaging, Technical University of Munich, München, Germany.
  • Lamberts LE; Institute for Biological and Medical Imaging, Helmholtz Zentrum München, München, Germany.
  • Adams AL; Chair for Biological Imaging, Technical University of Munich, München, Germany.
  • Kranendonk ME; Institute for Biological and Medical Imaging, Helmholtz Zentrum München, München, Germany.
  • Terwisscha van Scheltinga AG; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Aichler M; Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Jansen L; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • de Vries J; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Lub-de Hooge MN; Hospital and Clinical Pharmacy, University of Groningen, University Medical Center Groningen, the Netherlands.
  • Schröder CP; Research Unit Analytical Pathology, Helmholtz Zentrum München, München, Germany.
  • Jorritsma-Smit A; Department of Surgery, University of Groningen, University Medical Center Groningen, the Netherlands.
  • Linssen MD; Department of Surgery, University of Groningen, University Medical Center Groningen, the Netherlands.
  • de Boer E; Hospital and Clinical Pharmacy, University of Groningen, University Medical Center Groningen, the Netherlands.
  • van der Vegt B; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Nagengast WB; Hospital and Clinical Pharmacy, University of Groningen, University Medical Center Groningen, the Netherlands.
  • Elias SG; Hospital and Clinical Pharmacy, University of Groningen, University Medical Center Groningen, the Netherlands.
  • Oliveira S; Department of Surgery, University of Groningen, University Medical Center Groningen, the Netherlands.
  • Witkamp AJ; Department of Pathology, University of Groningen, University Medical Center Groningen, the Netherlands.
  • Mali WP; Department of Gastroenterology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Van der Wall E; Julius Center for Health Sciences and Primary Care, Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Garcia-Allende PB; Department of Biology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • van Diest PJ; Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
  • de Vries EG; Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Walch A; Department of Medical Oncology, Utrecht University, University Medical Center Utrecht, Utrecht, the Netherlands.
  • van Dam GM; Chair for Biological Imaging, Technical University of Munich, München, Germany.
  • Ntziachristos V; Institute for Biological and Medical Imaging, Helmholtz Zentrum München, München, Germany.
Cancer Res ; 77(3): 623-631, 2017 02 01.
Article em En | MEDLINE | ID: mdl-27879266
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Interpretação de Imagem Assistida por Computador / Imagem Molecular / Imagem Óptica / Bevacizumab Tipo de estudo: Guideline Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Interpretação de Imagem Assistida por Computador / Imagem Molecular / Imagem Óptica / Bevacizumab Tipo de estudo: Guideline Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha